Login / Signup

Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing.

Peter SchubertBrankica CulibrkVarsha BhaktaTatiana ClosasWilliam P SheffieldDana V DevineKen McTaggart
Published in: Transfusion (2022)
In vitro WB quality seems to be independent on the choice of anticoagulant and filtration timing supporting WB hold-times to up to 24 h, increasing operational flexibility for transfusion services.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • healthcare
  • primary care
  • quality improvement
  • mental health
  • cardiac surgery
  • sickle cell disease
  • decision making
  • health insurance
  • affordable care act